难治性抑郁症非药物治疗新进展

doi:10.3969/j.issn.1006-5725.2024.04.001

Abstract

Abstract:

Depression， with its characteristics of high prevalence， younger onset age， and high suicide rate， has repeatedly become the focus of societal discussion. It severely impairs the quality of life of patients and affects the development of the economy. Currently， treatments for depression are limited and vary in effectiveness. An increasing number of patients are classified as having treatment-resistant depression. In order to improve the cure rate further， numerous non-pharmacological treatments have been explored， among which physical therapies have garnered significant attention. This article provides a brief overview and discussion of recent physical treatments for treatment-resistant depression， offering new prospects for the field and inspiring readers with fresh ideas.

Key words: treatment-resistant depression, non-pharmacological treatment, personalized treatment

CLC Number:

R749

Rui XU,Xingbing. HUANG. Progress of non-pharmacological treatments for treatment-resistant depression[J]. The Journal of Practical Medicine, 2024, 40(4): 439-446.

References 66

1	MALHI G S， MANN J J. Depression［J］. Lancet （London， England）， 2018， 392（10161）： 2299-2312. doi:10.1016/s0140-6736(18)31948-2 doi: 10.1016/s0140-6736(18)31948-2
2	BERMAN R M， NARASIMHAN M， CHARNEY D S. Treatment-refractory depression： definitions and characteristics［J］. Depress Anxiety， 1997， 5（4）： 154-164. doi:10.1002/(sici)1520-6394(1997)5:4<154::aid-da2>3.0.co;2-d doi: 10.1002/(sici)1520-6394(1997)5:4<154::aid-da2>3.0.co;2-d
3	李凌江，马辛. 中国抑郁障碍防治指南［M］. 北京：中华医学电子音像出版社， 2015： 234.
4	RYBAK Y E， LAI K S P， RAMASUBBU R， et al. Treatment-resistant major depressive disorder： Canadian expert consensus on definition and assessment［J］. Depress Anxiety， 2021， 38（4）： 456-467. doi:10.1002/da.23135 doi: 10.1002/da.23135
5	安旭光，杨程皓. 难治性抑郁症的分级方法［J］. 四川精神卫生， 2016，29（6）： 583-586. doi:10.11886/j.issn.1007-3256.2016.06.021 doi: 10.11886/j.issn.1007-3256.2016.06.021
6	VOINESKOS D， DASKALAKIS Z J， BLUMBERGER D M. Management of Treatment-Resistant Depression： Challenges and Strategies［J］. Neuropsychiatr Dis Treat， 2020， 16： 221-234. doi:10.2147/ndt.s198774 doi: 10.2147/ndt.s198774
7	GBYL K， ROSTRUP E， RAGHAVA J M， et al. Volume of hippocampal subregions and clinical improvement following electroconvulsive therapy in patients with depression［J］. Prog NeuroPsychopharmacol Biol Psychiatry， 2021， 104： 110048. doi:10.1016/j.pnpbp.2020.110048 doi: 10.1016/j.pnpbp.2020.110048
8	MESHKAT S， ALNEFEESI Y， JAWAD M Y， et al. Brain-Derived Neurotrophic Factor （BDNF） as a biomarker of treatment response in patients with Treatment Resistant Depression （TRD）： A systematic review & meta-analysis［J］. Psychiatry Res， 2022， 317： 114857. doi:10.1016/j.psychres.2022.114857 doi: 10.1016/j.psychres.2022.114857
9	ARGYELAN M， OLTEDAL L， DENG Z D， et al. Electric field causes volumetric changes in the human brain［J］. eLife， 2019， 8： e49115. doi:10.7554/elife.49115 doi: 10.7554/elife.49115
10	FRIDGEIRSSON E A， DENG Z D， DENYS D， et al. Electric field strength induced by electroconvulsive therapy is associated with clinical outcome［J］. Neuro Image Clin， 2021， 30： 102581. doi:10.1016/j.nicl.2021.102581 doi: 10.1016/j.nicl.2021.102581
11	DOMINIAK M， ANTOSIK-WÓJCIŃSKA A Z， GOETZ Z， et al. Efficacy， safety and tolerability of formula-based unilateral vs bilateral electroconvulsive therapy in the treatment of major depression： A randomized open label controlled trial［J］. J Psychiatr Res， 2021， 133： 52-59. doi:10.1016/j.jpsychires.2020.12.002 doi: 10.1016/j.jpsychires.2020.12.002
12	MUTZ J， VIPULANANTHAN V， CARTER B， et al. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults： systematic review and network meta-analysis［J］. BMJ， 2019， 364： l1079. doi:10.1136/bmj.l1079 doi: 10.1136/bmj.l1079
13	REGENOLD W T， NOORANI R J， PIEZ D， et al. Nonconvulsive Electrotherapy for Treatment Resistant Unipolar and Bipolar Major Depressive Disorder： A Proof-of-concept Trial［J］. Brain Stimul， 2015， 8（5）： 855-861. doi:10.1016/j.brs.2015.06.011 doi: 10.1016/j.brs.2015.06.011
14	ZHENG W， JIANG M L， HE H B， et al. A Preliminary Study of Adjunctive Nonconvulsive Electrotherapy for Treatment-Refractory Depression［J］. Psychiatr Q， 2021， 92（1）： 311-320. doi:10.1007/s11126-020-09798-3 doi: 10.1007/s11126-020-09798-3
15	YOON I Y， RYU J H， DO S H， et al. Etomidate versus Propofol for Electroconvulsive Therapy in Patients with Major Depressive Disorders in Terms of Clinical Responses to Treatment： A Retrospective Analysis［J］. Brain Sci， 2023， 13（7）： 1023. doi:10.3390/brainsci13071023 doi: 10.3390/brainsci13071023
16	LI K J， SLAMA N E， HIRSCHTRITT M E， et al. Electroconvulsive Therapy Anesthetic Choice and Clinical Outcomes［J］. J ECT， 2023， 39（2）： 102-105. doi:10.1097/yct.0000000000000895 doi: 10.1097/yct.0000000000000895
17	GONZALEZ S， VASAVADA M， NJAU S， et al. Acute changes in cerebral blood flow after single-infusion ketamine in major depression： a pilot study［J］. Neurol Psychiatry Brain Res， 2020， 38： 5-11. doi:10.1016/j.npbr.2020.08.006 doi: 10.1016/j.npbr.2020.08.006
18	MODIR H， MAHMOODIYEH B， SHAYGANFARD M， et al. Efficacy of ketamine， propofol， and dexmedetomidine for anesthesia in electroconvulsive therapy in treatment-resistant major depressive disorder patients： a double-blind randomized clinical trial［J］. Med Gas Res， 2023， 13（3）： 112-117. doi:10.4103/2045-9912.350860 doi: 10.4103/2045-9912.350860
19	WOOLSEY A J， NANJI J A， MOREAU C， et al. Low-dose ketamine does not improve the speed of recovery from depression in electroconvulsive therapy： a randomized controlled trial［J］. Braz J Psychiatry， 2022， 44（1）： 6-14. doi:10.1590/1516-4446-2020-1705 doi: 10.1590/1516-4446-2020-1705
20	陈运良，熊朝晖，王晓斌，等. 小剂量氯胺酮复合丙泊酚麻醉对电休克抽搐发作的影响［J］. 实用医学杂志， 2013，29（3）： 459-461. doi:10.3969/j.issn.1006-5725.2013.03.046 doi: 10.3969/j.issn.1006-5725.2013.03.046
21	黄兴兵，梅芳，黄雄，等. 不同麻醉剂无抽搐电休克治疗难治性抑郁症的疗效比较［J］. 实用医学杂志， 2015，31（17）：2808-2811. doi:10.3969/j.issn.1006-5725.2015.17.014 doi: 10.3969/j.issn.1006-5725.2015.17.014
22	MEMON R I， NAVEED S， FAQUIH A E， et al. Effectiveness and Safety of Ketamine for Unipolar Depression： a Systematic Review［J］. Psychiatr Q， 2020， 91（4）： 1147-1192. doi:10.1007/s11126-020-09830-6 doi: 10.1007/s11126-020-09830-6
23	MOLERO P， RAMOS-QUIROGA J A， MARTIN-SANTOS R， et al. Antidepressant Efficacy and Tolerability of Ketamine and Esketamine： A Critical Review［J］. CNS Drugs， 2018， 32（5）： 411-420. doi:10.1007/s40263-018-0519-3 doi: 10.1007/s40263-018-0519-3
24	SARTORIUS A， BEUSCHLEIN J， REMENNIK D， et al. Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure quality［J］. Eur Arch Psychiatry Clin Neurosci， 2021， 271（3）： 457-463. doi:10.1007/s00406-020-01170-7 doi: 10.1007/s00406-020-01170-7
25	ROSSON S， DE FILIPPIS R， CROATTO G， et al. Brain stimulation and other biological non-pharmacological interventions in mental disorders： An umbrella review［J］. Neurosci Biobehav Rev， 2022， 139： 104743. doi:10.1016/j.neubiorev.2022.104743 doi: 10.1016/j.neubiorev.2022.104743
26	KAYSER S， BEWERNICK B H， GRUBERT C， et al. Antidepressant effects， of magnetic seizure therapy and electroconvulsive therapy， in treatment-resistant depression［J］. J Psychiatr Res， 2011， 45（5）： 569-576. doi:10.1016/j.jpsychires.2010.09.008 doi: 10.1016/j.jpsychires.2010.09.008
27	CHEN M， YANG X， LIU C， et al. Comparative efficacy and cognitive function of magnetic seizure therapy vs. electroconvulsive therapy for major depressive disorder： a systematic review and meta-analysis［J］. Transll Psychiatry， 2021， 11（1）： 437. doi:10.1038/s41398-021-01560-y doi: 10.1038/s41398-021-01560-y
28	WEISSMAN C R， BLUMBERGER D M， DIMITROVA J， et al. Magnetic Seizure Therapy for Suicidality in Treatment-Resistant Depression［J］. JAMA Netw Open， 2020， 3（8）： e207434. doi:10.1001/jamanetworkopen.2020.7434 doi: 10.1001/jamanetworkopen.2020.7434
29	JIANG J， ZHANG C， LI C， et al. Magnetic seizure therapy for treatment-resistant depression［J］. Cochrane Database Syst Rev， 2021， 6（6）： CD013528. doi:10.1002/14651858.cd013528.pub2 doi: 10.1002/14651858.cd013528.pub2
30	LI H， CUI L， LI J， et al. Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression： a network meta-analysis of randomized controlled trials［J］. J Affect Disord 2021， 287： 115-124. doi:10.1016/j.jad.2021.03.019 doi: 10.1016/j.jad.2021.03.019
31	MILEV R V， GIACOBBE P， KENNEDY S H， et al. Canadian Network for Mood and Anxiety Treatments （CANMAT） 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder： Section 4. Neurostimulation Treatments［J］. Can J Psychiatry， 2016， 61（9）： 561-575. doi:10.1177/0706743716660033 doi: 10.1177/0706743716660033
32	SONMEZ A I， CAMSARI D D， NANDAKUMAR A L， et al. Accelerated TMS for Depression： A systematic review and meta-analysis［J］. Psychiatry Res， 2019， 273： 770-781. doi:10.1016/j.psychres.2018.12.041 doi: 10.1016/j.psychres.2018.12.041
33	RACHID F. Accelerated transcranial magnetic stimulation for the treatment of Patients with depression： A review［J］. Asian J Psychiatr， 2019， 40： 71-75. doi:10.1016/j.ajp.2019.02.003 doi: 10.1016/j.ajp.2019.02.003
34	ROTH Y， HANLON C A， PELL G， et al. Real world efficacy and safety of various accelerated deep TMS protocols for major depression［J］. Psychiatry Res， 2023， 328： 115482. doi:10.1016/j.psychres.2023.115482 doi: 10.1016/j.psychres.2023.115482
35	KISHI T， SAKUMA K， MATSUDA Y， et al. Intermittent theta burst stimulation vs. high-frequency repetitive transcranial magnetic stimulation for major depressive disorder： A systematic review and meta-analysis［J］. Psychiatry Res， 2023， 328： 115452. doi:10.1016/j.psychres.2023.115452 doi: 10.1016/j.psychres.2023.115452
36	CHEN M H， CHENG C M， LI C T， et al. Comparative study of low-dose ketamine infusion and repetitive transcranial magnetic stimulation in treatment-resistant depression： A posthoc pooled analysis of two randomized， double-blind， placebo-controlled studies［J］. Psychiatry Res， 2022， 316： 114749. doi:10.1016/j.psychres.2022.114749 doi: 10.1016/j.psychres.2022.114749
37	BLUMBERGER D M， VILA-RODRIGUEZ F， WANG W， et al. A randomized sham controlled comparison of once vs twice-daily intermittent theta burst stimulation in depression： A Canadian rTMS treatment and biomarker network in depression （CARTBIND） study［J］. Brain Stimul， 2021， 14（6）： 1447-1455. doi:10.1016/j.brs.2021.09.003 doi: 10.1016/j.brs.2021.09.003
38	COLE E J， STIMPSON K H， BENTZLEY B S， et al. Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression［J］. Am J Psychiatry， 2020， 177（8）： 716-726. doi:10.1176/appi.ajp.2019.19070720 doi: 10.1176/appi.ajp.2019.19070720
39	唐乃龙，陈怡环，王洋涛，等. 个体化靶向机器人技术辅助斯坦福加速智能神经调节疗法精准治疗伴自杀观念的抑郁症患者的初步研究［J］. 中华精神科杂志， 2022， 55（1）： 14-23. doi:10.3760/cma.j.cn113661-20210527-00173 doi: 10.3760/cma.j.cn113661-20210527-00173
40	ELYAMANY O， LEICHT G， HERRMANN C S， et al. Transcranial alternating current stimulation （tACS）： from basic mechanisms towards first applications in psychiatry［J］. Eur Arch Psychiatry Clin Neurosci， 2021， 271（1）： 135-156. doi:10.1007/s00406-020-01209-9 doi: 10.1007/s00406-020-01209-9
41	WANG H， WANG K， XUE Q， et al. Transcranial alternating current stimulation for treating depression： a randomized controlled trial［J］. Brain， 2022， 145（1）： 83-91. doi:10.1093/brain/awab252 doi: 10.1093/brain/awab252
42	QASEM W AL， ABUBAKER M， KVAŠŇÁK E. Working Memory and Transcranial-Alternating Current Stimulation-State of the Art： Findings， Missing， and Challenges［J］. Front Psychol， 2022， 13： 822545. doi:10.3389/fpsyg.2022.822545 doi: 10.3389/fpsyg.2022.822545
43	GUERRA A， ASCI F， ZAMPOGNA A， et al. Gamma-transcranial alternating current stimulation and theta-burst stimulation： inter-subject variability and the role of BDNF［J］. Clin Neurophysiol， 2020， 131（11）： 2691-2699. doi:10.1016/j.clinph.2020.08.017 doi: 10.1016/j.clinph.2020.08.017
44	WOODHAM R， RIMMER R M， MUTZ J， et al. Is tDCS a potential first line treatment for major depression？［J］. Int Rev Psychiatry， 2021， 33（3）： 250-265. doi:10.1080/09540261.2021.1879030 doi: 10.1080/09540261.2021.1879030
45	NIKOLIN S， MOFFA A， RAZZA L， et al. Time-course of the tDCS antidepressant effect： An individual participant data meta-analysis［J］. Prog Neuropsychopharmacol Biol Psychiatry， 2023， 125： 110752. doi:10.1016/j.pnpbp.2023.110752 doi: 10.1016/j.pnpbp.2023.110752
46	BENNABI D， NICOLIER M， MONNIN J， et al. Pilot study of feasibility of the effect of treatment with tDCS in patients suffering from treatment-resistant depression treated with escitalopram［J］. Clin Neurophysiol， 2015， 126（6）： 1185-1189. doi:10.1016/j.clinph.2014.09.026 doi: 10.1016/j.clinph.2014.09.026
47	PALM U， SCHILLER C， FINTESCU Z， et al. Transcranial direct current stimulation in treatment resistant depression： a randomized double-blind， placebo-controlled study［J］. Brain Stimul， 2012， 5（3）： 242-251. doi:10.1016/j.brs.2011.08.005 doi: 10.1016/j.brs.2011.08.005
48	MARTIN D M， TENG J Z， LO T Y， et al.Clinical pilot study of transcranial direct current stimulation combined with Cognitive Emotional Training for medication resistant depression［J］. J Affect Disord，2018，232：89-95. doi:10.1016/j.jad.2018.02.021 doi: 10.1016/j.jad.2018.02.021
49	HU Y Y， YANG G， LIANG X S， et al. Transcranial low-intensity ultrasound stimulation for treating central nervous system disorders： A promising therapeutic application［J］. Front Neurol， 2023， 14： 1117188. doi:10.3389/fneur.2023.1117188 doi: 10.3389/fneur.2023.1117188
50	HUANG Y， ALKINS R， SCHWARTZ M L，et al. Opening the Blood-Brain Barrier with MR Imaging-guided Focused Ultrasound： Preclinical Testing on a Trans-Human Skull Porcine Model［J］.Radiology，2017，282（1）：123-130. doi:10.1148/radiol.2016152154 doi: 10.1148/radiol.2016152154
51	CATTARINUSSI G， MOGHADDAM H S， AARABI M H， et al. White Matter Microstructure Associated with the Antidepressant Effects of Deep Brain Stimulation in Treatment-Resistant Depression： A Review of Diffusion Tensor Imaging Studies［J］. Int J Mol Sci， 2022， 23（23）： 15379. doi:10.3390/ijms232315379 doi: 10.3390/ijms232315379
52	ZHU Z， HUBBARD E， GUO X， et al. A connectomic analysis of deep brain stimulation for treatment-resistant depression［J］. Brain Stimul， 2021， 14（5）： 1226-1233. doi:10.1016/j.brs.2021.08.010 doi: 10.1016/j.brs.2021.08.010
53	FIGEE M， RIVA-POSSE P， CHOI K S， et al. Deep Brain Stimulation for Depression［J］. Neurotherapeutics， 2022， 19（4）： 1229-1245. doi:10.1007/s13311-022-01270-3 doi: 10.1007/s13311-022-01270-3
54	REIF-LEONHARD C， REIF A， BAUNE B T， et al. Vagus nerve stimulation for difficult to treat depression［J］. Der Nervenarzt， 2022， 93（9）： 921-930. doi:10.1007/s00115-022-01282-6 doi: 10.1007/s00115-022-01282-6
55	AARONSON S T， SEARS P， RUVUNA F， et al. A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual： Comparison of Response， Remission， and Suicidality［J］. Am J Psychiatry， 2017， 174（7）： 640-648. doi:10.1176/appi.ajp.2017.16010034 doi: 10.1176/appi.ajp.2017.16010034
56	RUSH A J， MARANGELL L B， SACKEIM H A， et al. Vagus nerve stimulation for treatment-resistant depression： a randomized， controlled acute phase trial［J］. Biol Psychiatry， 2005， 58（5）： 347-354. doi:10.1016/j.biopsych.2005.05.025 doi: 10.1016/j.biopsych.2005.05.025
57	周晶晶，贾圣陶，张晓华，等. 迷走神经刺激术治疗5例难治性抑郁症患者的疗效及安全性分析［J］. 神经疾病与精神卫生， 22022，22（3）： 172-176.
58	ARMOUR M， SMITH C A， WANG L Q， et al. Acupuncture for Depression： A Systematic Review and Meta-Analysis［J］. J Clin Med， 2019， 8（8）： 1140. doi:10.3390/jcm8081140 doi: 10.3390/jcm8081140
59	XU G， LEI H， HUANG L， et al. The dose-effect association between acupuncture sessions and its effects on major depressive disorder： A meta-regression of randomized controlled trials［J］. J Affect Disord， 2022， 310： 318-327. doi:10.1016/j.jad.2022.04.155 doi: 10.1016/j.jad.2022.04.155
60	XU M M， GUO P， MA Q Y， et al. Can acupuncture enhance therapeutic effectiveness of antidepressants and reduce adverse drug reactions in patients with depression？ A systematic review and meta-analysis［J］. J Integr Med， 2022， 20（4）： 305-320. doi:10.1016/j.joim.2022.05.002 doi: 10.1016/j.joim.2022.05.002
61	CHEN B， WANG C C， LEE K H， et al. Efficacy and safety of acupuncture for depression： A systematic review and meta-analysis［J］. Res Nurs Health， 2023， 46（1）： 48-67. doi:10.1002/nur.22284 doi: 10.1002/nur.22284
62	SVERRE K T， NISSEN E R， FARVER-VESTERGAARD I， et al. Comparing the efficacy of mindfulness-based therapy and cognitive-behavioral therapy for depression in head-to-head randomized controlled trials： A systematic review and meta-analysis of equivalence［J］. Clin Psychol Rev， 2023， 100： 102234. doi:10.1016/j.cpr.2022.102234 doi: 10.1016/j.cpr.2022.102234
63	ZHANG B， FU W， GUO Y， et al. Effectiveness of mindfulness-based cognitive therapy against suicidal ideation in patients with depression： A systematic review and meta-analysis［J］. J Affect Disord， 2022， 319： 655-662. doi:10.1016/j.jad.2022.09.091 doi: 10.1016/j.jad.2022.09.091
64	LI X， LAPLANTE D P， PAQUIN V， et al. Effectiveness of cognitive behavioral therapy for perinatal maternal depression， anxiety and stress： A systematic review and meta-analysis of randomized controlled trials［J］. Clin Psychol Rev， 2022， 92： 102129. doi:10.1016/j.cpr.2022.102129 doi: 10.1016/j.cpr.2022.102129
65	GALIMA S V， VOGEL S R， KOWALSKI A W. Seasonal Affective Disorder： Common Questions and Answers［J］. Am Fam Physician， 2020， 102（11）： 668-672.
66	MITTER P， DE CRESCENZO F， YONG KEE K LOO， et al. Sleep deprivation as a treatment for major depressive episodes： A systematic review and meta-analysis［J］. Sleep Med Rev， 2022， 64： 101647. doi:10.1016/j.smrv.2022.101647 doi: 10.1016/j.smrv.2022.101647

[1]	Tianyue YU,Qian GUO,Hao HU,Yujing SU,Jianhua CHEN. Advances in oxidative stress⁃related pathways with diagnostic and predictive value in schizophrenia [J]. The Journal of Practical Medicine, 2024, 40(20): 2935-2940.
[2]	Zheng ZHANG,Zhengqian JIANG,Jiali LIU,Xia CAO,Jiansong. ZHOU. Development of digital therapy in the diagnosis and treatment of psychiatric disorders [J]. The Journal of Practical Medicine, 2024, 40(18): 2513-2519.
[3]	Zhiyan XU,Weiyuan CHEN,Weifeng. YAO. Mechanism and research progress of dexmedetomidine in improving perioperative neurocognitive disorder in frail elderly patients [J]. The Journal of Practical Medicine, 2024, 40(17): 2503-2507.
[4]	. [J]. The Journal of Practical Medicine, 2024, 40(12): 1677-1682.
[5]	Qiaofang HUANG,Xingxiao HUANG,Junyi LIN,Lian DUAN,Zhentai PANG,Shaojuan WU,Caimei ZOU,Shichao XU. Effect of physician⁃nurse⁃social worker linkage rehabilitation model on psychological status in patients receiving methadone maintenance treatment [J]. The Journal of Practical Medicine, 2024, 40(9): 1238-1243.
[6]	Bing LIU,Hanxi CHEN,Wenji LIU,Yingwen HUANG,Yan WANG,Chan HUANG,Tianhui. YOU. Impacts of illness perception and coping style on social participation in patients receiving surgery for Stanford type A aortic dissection [J]. The Journal of Practical Medicine, 2024, 40(8): 1160-1166.
[7]	Shuangyan LI,Bin ZHANG. Research status and challenges of insomnia disorder [J]. The Journal of Practical Medicine, 2024, 40(6): 731-737.
[8]	Xilin WANG,Chanjuan YANG,Daomeng. CHENG. Construction of a nomogram prediction model for aggressive behavior in patients with bipolar disorder [J]. The Journal of Practical Medicine, 2024, 40(5): 677-681.
[9]	Yonghui LIU,Qingjing TAN,Qing CHEN,Liping WEI,Junwei YANG,Kan YANG,Yuguang. GAO. The mechanism of target regulating of miR⁃421 to Menin/Caspase⁃3 pathway for depression [J]. The Journal of Practical Medicine, 2024, 40(4): 453-459.
[10]	Li LI,Lin. TANG. Analysis of influencing factors of non⁃suicidal self⁃injury behavior and motivation in adult patients with depression [J]. The Journal of Practical Medicine, 2024, 40(4): 466-470.
[11]	Xia NAN,Wenling LI,Lin. WANG. Advances in MRI studies of brain structure and cerebral blood perfusion in patients with bipolar disorder [J]. The Journal of Practical Medicine, 2024, 40(4): 580-584.
[12]	Yanlin LIU,Hui LI,Xiaoliang. ZHOU. Effects of different doses of sodium valproate on serum TSH， PRL and DA levels in patients with bipolar disorder [J]. The Journal of Practical Medicine, 2024, 40(1): 97-101.
[13]	Yaxin YANG,Mao HUANG,Xin WANG,Yaru ZHI,Xuemeng SHI,Hongjin REN,Wanying. PENG. Effect of head acupuncturing therapy combined with massaging key head acupoints on language and cognitive function in children with autism [J]. The Journal of Practical Medicine, 2023, 39(23): 3132-3136.
[14]	Na LIU,Tiandao WANG,Chunliu YU,Yi. CHEN. Relationships of prognosis of schizophrenic patients with their serum prolactin and glial fibrillary acid protein [J]. The Journal of Practical Medicine, 2023, 39(16): 2090-2094.

Progress of non-pharmacological treatments for treatment-resistant depression

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 66

Related Articles 14

Recommended Articles

Metrics

Comments